📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
73 announcements match the current filters (relevance ≥ 5).
UGRO Capital Concludes 33rd AGM; Re-appoints Shachindra Nath as MD and Approves ESOPs
UGRO Capital held its 33rd Annual General Meeting on May 29, 2026, to approve the audited financial statements for the fiscal year ending March 31, 2026. Key management decisions included the re-appointment of Mr. Shachindra Nath as Vice Chairman and Managing Director and the appointment of M/s G.P. Kapadia & Co. as Statutory Auditors. The company also sought approval for variable compensation for the MD and the issuance of ESOPs to subsidiary employees under the 2022 scheme. Voting results will be disclosed separately following the scrutinizer's report.
Key Highlights
Adoption of Audited Standalone and Consolidated Financial Statements for the year ended March 31, 2026.
Re-appointment of Mr. Shachindra Nath as Vice Chairman and Managing Director of the company.
Approval for variable compensation and payment of unpaid fixed compensation for the Managing Director.
Grant of Employee Stock Options (ESOPs) to subsidiary employees under the 2022 Scheme.
Appointment of M/s G.P. Kapadia & Co. as the Statutory Auditors.
👀 What to Watch
Investors should review the final voting results once published to gauge shareholder sentiment regarding executive compensation and ESOP dilution. The re-appointment of the MD ensures leadership continuity.
UGRO Capital Clarifies MD Pay: Proposed ₹10 Cr Package Below Market Median
UGRO Capital has issued a detailed clarification following a media report regarding proxy advisory concerns over MD Shachindra Nath's compensation. The company asserts that the proposed ₹10 crore package (₹7 crore fixed and ₹3 crore deferred) is at or below the market median according to an independent Aon study. A critical distinction is that Mr. Nath, as a promoter by law, is ineligible for ESOPs and SARs, unlike his peers whose total compensation includes significant equity components. The board also highlighted that Mr. Nath has personally guaranteed ₹1,830 crore of company debt without charging any commission.
Key Highlights
Proposed total compensation of ₹10 crore is benchmarked at or below market median for comparable NBFC MDs.
MD Shachindra Nath is excluded from ESOPs/SARs due to promoter status, making cash-only peer comparisons structurally incomplete.
Mr. Nath has provided personal guarantees for ₹1,830 crore of institutional borrowings without any fee or commission.
Company cited precedents of Five-Star Business Finance and SBFC Finance where shareholders approved pay despite proxy advisor 'Against' recommendations.
Variable pay is an enabling resolution to align founder interests with share price appreciation, overseen by a 100% independent NRC.
👀 What to Watch
Investors should monitor the upcoming AGM voting results to gauge institutional sentiment regarding the remuneration package. The MD's significant personal guarantee of ₹1,830 crore suggests high alignment with the company's solvency and performance.
UGRO Capital Allots Secured NCDs Worth INR 200 Crores at 9.75% Coupon
UGRO Capital has approved the allotment of 2,00,000 senior secured Non-Convertible Debentures (NCDs) totaling INR 200 crores through a private placement. These NCDs carry a coupon rate of 9.75% per annum, which will be paid out on a monthly basis. The instrument has a relatively short tenure of 18 months, with a maturity date set for November 26, 2027. This capital infusion will likely be utilized to expand the company's lending book and manage liquidity.
Key Highlights
Total allotment of 2,00,000 NCDs with a face value of INR 10,000 each, aggregating to INR 200 crores.
Fixed coupon rate of 9.75% per annum with a monthly interest payment schedule.
Short-term tenure of 18 months with maturity scheduled for November 2027.
The NCDs are senior, secured, and will be listed on the BSE Limited.
Security includes a first ranking floating charge on identified loan receivables and cash equivalents.
👀 What to Watch
Investors should monitor how effectively the company deploys this capital to grow its AUM while maintaining asset quality. The ability to raise funds at sub-10% rates is a positive indicator of lender confidence in UGRO's business model.
UGRO Capital to Re-appoint Shachindra Nath as MD for 5 Years; AGM Set for May 29, 2026
UGRO Capital has issued a notice for its 33rd Annual General Meeting (AGM) scheduled for May 29, 2026. The primary agenda includes the re-appointment of Mr. Shachindra Nath as Vice Chairman and Managing Director for a five-year term with a proposed total fixed compensation of ₹10 Crores for FY 2026-27. The notice highlights the MD's significant 'skin-in-the-game,' including personal guarantees of ₹1,830 Crores provided to lenders and a personal equity investment of ₹40 Crores. Other routine matters include the appointment of M/s G.P. Kapadia & Co. as Statutory Auditors.
Key Highlights
Re-appointment of Shachindra Nath as VC & MD for a 5-year term effective June 22, 2026.
Proposed total fixed compensation for the MD set at ₹10 Crores for FY 2026-27 (₹7 Cr base + ₹3 Cr deferred).
MD has provided personal guarantees worth approximately ₹1,830 Crores to company lenders without fees.
MD maintains a personal equity investment of approximately ₹40 Crores in the company.
Appointment of M/s G.P. Kapadia & Co. as Statutory Auditors until the 36th AGM.
👀 What to Watch
Investors should take confidence in the leadership continuity and the MD's substantial personal financial commitment to the firm's stability. The high level of personal guarantees and equity holding aligns management interests closely with those of the shareholders.
UGRO Capital Appoints Satyabrata Mohapatra as COO Following Sharad Agarwal's Resignation
UGRO Capital has announced a transition in its senior leadership with the resignation of Mr. Sharad Agarwal, the Chief Operations & Technology Officer, effective May 5, 2026. To ensure continuity, the company has promoted Mr. Satyabrata Mohapatra, an internal candidate with over 4 years of experience at the firm, to the role of Chief Operations Officer. Mr. Mohapatra brings 20 years of total industry experience, having previously managed critical functions like co-lending and treasury operations. This internal promotion aims to maintain the company's growth trajectory and operational stability.
Key Highlights
Mr. Sharad Agarwal resigned from his position as Chief Operations & Technology Officer on May 5, 2026.
Mr. Satyabrata Mohapatra, previously Head of Operations & Customer Service, is appointed as the new COO.
The new appointee has 20 years of experience and has been instrumental in scaling UGRO's operations over the last 4 years.
Mr. Mohapatra's expertise spans Branch, Central, Co-lending, Treasury, and SCF Operations.
👀 What to Watch
Investors should view this as a routine leadership transition; however, they should monitor for any future appointments regarding the 'Technology' portfolio which was previously held by the outgoing officer. No immediate action is required as the internal promotion suggests strong succession planning.
UGRO Capital Q4 FY26: Net Total Income Up 51% YoY; Targets INR 220 Cr Annual Cost Savings
UGRO Capital reported a 51% YoY growth in Net Total Income for Q4 FY26, driven by a strategic shift towards high-yield Emerging Market LAP and Embedded Finance. The company is executing a major realignment to exit low-yield intermediated books, targeting INR 220 crore in annualized cost savings by FY27. While AUM remained flat QoQ due to the intentional run-down of non-focus segments, focus verticals now comprise 38% of the total book. Management maintains a healthy capital adequacy of 21.2% and expects to reach a 3-3.5% ROA by FY29 without further equity dilution.
Key Highlights
Net Total Income grew 51% YoY to INR 415 Cr in Q4 FY26, while PAT rose 26% YoY despite a one-time restructuring cost of INR 25 Cr.
Focus verticals (EM-LAP and Embedded Finance) increased to 38% of total AUM, with Embedded Finance growing 27% QoQ to INR 2,280 Cr.
Annualized cost savings of INR 220 Cr are on track, with opex projected to fall from INR 750 Cr to INR 490 Cr+ in FY27.
Cost of borrowings improved for the fifth consecutive quarter to 10.16%, down 45 bps YoY.
Asset quality remains stable with EM-LAP GNPA at 1.2% and overall GNPA at 2.5% due to the run-down of the non-focus book.
👀 What to Watch
Investors should monitor the successful execution of the INR 220 Cr cost-reduction plan and the scale-up of the high-yield Embedded Finance segment. The shift toward a high-ROA annuity model suggests strong long-term value creation potential.
UGRO Capital Q4'FY26: PAT Grows 26% YoY to ₹51.1 Cr; Focus Vertical AUM Hits 38%
UGRO Capital reported a 26% YoY increase in PAT to ₹51.1 Cr for Q4'FY26, driven by a strategic shift toward high-yield focus verticals which now constitute 38% of AUM. The company is executing a cost rationalization plan following the Profectus consolidation, targeting annualized savings of ₹200-220 Cr. Capital Adequacy improved to 21.2%, supporting management's commitment to avoid incremental equity raises for the next three years. While GNPA rose slightly to 2.5% due to a marginal decline in total AUM, the transition to an annuity-led ROA model remains on track.
Key Highlights
Total AUM grew 28% YoY to ₹15,334 Cr, with focus verticals (EM + Embedded Finance) growing 17% QoQ
Reported ROA and ROE stood at 2.1% and 7.1% respectively, including one-time exit costs of ₹25.4 Cr
Capital Adequacy Ratio (CAR) improved to 21.2% from 20.8% in Dec-25, with Net Worth at ₹2,906 Cr
Embedded Merchant Lending AUM surged 27% QoQ to ₹2,280 Cr across 250k active customers
Branch productivity for mature Emerging Market branches reached ₹0.68 Cr/month, nearing the ₹0.80 Cr target
👀 What to Watch
Investors should view the successful pivot to high-yield segments and the 'no-dilution' commitment as strong positives for long-term value. Monitor the productivity of the 156 new branches and the stabilization of credit costs in the Embedded Merchant Finance portfolio.
UGRO Capital Q4 FY26 PAT Rises 26% to ₹51.1 Cr; AUM Hits ₹15,334 Cr
UGRO Capital reported a strong 26% YoY growth in Q4 FY26 PAT to ₹51.1 crore, while full-year profit reached ₹174.8 crore. Total AUM grew 28% YoY to ₹15,334 crore, driven by a strategic shift toward high-yield verticals like Emerging Market LAP and Embedded Finance. The company successfully executed ₹200-220 crore in annualized cost savings and maintained a healthy CRAR of 21.2%. Management reaffirmed its commitment to no further equity dilution through FY29 while targeting a 3.0-3.5% ROA.
Key Highlights
Q4 FY26 PAT grew 26% YoY to ₹51.1 Cr; FY26 PAT increased 21% to ₹174.8 Cr
Total AUM reached ₹15,334 Cr (+28% YoY), with high-yield focus verticals now 38% of the mix
Asset quality remains stable with GNPA at 2.50% and NNPA at 1.60%
Net Total Income for Q4 surged 51% YoY to ₹348 Cr, reflecting a shift to higher-yield on-book assets
Management confirmed no equity raise will be required through FY29, with a target ROA of 3.0-3.5%
👀 What to Watch
Investors should monitor the successful transition toward the high-yield annuity-led model and the improvement in ROA toward the 3% target. The commitment to no equity dilution until FY29 is a significant positive for existing shareholders.
Ugro Capital FY26 Revenue Up 26.5%, Plans ₹3,000 Cr NCD Fundraise & Re-appoints MD
Ugro Capital reported a strong financial performance for FY26, with total revenue rising to ₹1,766.24 crore from ₹1,395.90 crore in FY25. The Board has approved a significant fundraise of up to ₹3,000 crore through Non-Convertible Debentures (NCDs) to support its lending operations. Key leadership stability is ensured with the re-appointment of Mr. Shachindra Nath as MD for a five-year term. Additionally, the company is transitioning its statutory auditors to M/s G.P. Kapadia & Co. starting from the upcoming AGM.
Key Highlights
Total revenue from operations grew 26.5% YoY to ₹1,76,624 lakh in FY26
Approved issuance of Non-Convertible Debentures (NCDs) up to ₹3,000 crore via private placement
Re-appointed Mr. Shachindra Nath as Vice Chairman and Managing Director for a 5-year term starting June 2026
Interest income saw a robust increase to ₹1,27,293 lakh compared to ₹95,880 lakh in the previous fiscal
Appointed M/s G.P. Kapadia & Co. as Statutory Auditors for a 3-year term starting FY27
👀 What to Watch
The strong revenue growth and massive ₹3,000 crore fundraise indicate aggressive expansion plans; investors should monitor the company's ability to maintain asset quality as it scales its loan book.
Ugro Capital FY26 Revenue Grows 26% to ₹1,766 Cr; Board Approves ₹3,000 Cr NCD Fundraise
Ugro Capital reported a robust financial performance for FY26, with total revenue from operations rising to ₹1,766.24 crore, up from ₹1,395.90 crore in FY25. The company demonstrated strong operational growth with interest income increasing by 32.7% year-on-year to ₹1,272.93 crore. To fuel further expansion, the board has approved a massive fundraise of up to ₹3,000 crore through Non-Convertible Debentures (NCDs). Leadership stability is also secured with the re-appointment of Mr. Shachindra Nath as Vice Chairman and Managing Director for a five-year term.
Key Highlights
Total revenue for FY26 reached ₹1,766.24 crore, a 26.5% increase over FY25's ₹1,395.90 crore.
Interest income for the full year grew significantly to ₹1,272.93 crore from ₹958.80 crore in the previous year.
Board approved a significant fundraise of up to ₹3,000 crore via private placement of Non-Convertible Debentures.
Mr. Shachindra Nath re-appointed as VC & MD for a five-year tenure effective June 22, 2026.
Q4 FY26 revenue stood at ₹487.96 crore, reflecting strong quarterly momentum compared to ₹403.18 crore in Q4 FY25.
👀 What to Watch
The combination of strong double-digit revenue growth and a large ₹3,000 crore capital buffer for lending suggests a bullish outlook for the company's scale-up phase. Investors should monitor the cost of borrowing for the new NCDs and the execution of the growth strategy under the re-appointed leadership.
UGRO Capital FY26 Revenue Jumps 26.5% to ₹1,766 Cr; Board Approves ₹3,000 Cr NCD Fundraise
UGRO Capital reported a robust financial performance for FY26, with total revenue from operations growing to ₹1,766.24 crore from ₹1,395.90 crore in the previous year. The Board has approved a significant fundraise of up to ₹3,000 crore through Non-Convertible Debentures (NCDs) to support its expansion strategy. Leadership stability is secured with the re-appointment of Mr. Shachindra Nath as Managing Director for a five-year term. The company also announced a change in statutory auditors to M/s G.P. Kapadia & Co. following the completion of the current auditor's tenure.
Key Highlights
Annual revenue from operations increased by 26.5% YoY to ₹1,766.24 crore in FY26.
Board approved a massive fundraise of up to ₹3,000 crore via private placement of NCDs.
Interest income for FY26 rose significantly to ₹1,272.93 crore compared to ₹958.80 crore in FY25.
Q4 FY26 revenue stood at ₹487.96 crore, reflecting a 21% growth over Q4 FY25.
Mr. Shachindra Nath re-appointed as Vice Chairman and MD for a 5-year term effective June 2026.
👀 What to Watch
Investors should take note of the strong revenue momentum and the ambitious ₹3,000 crore fundraise, which signals aggressive growth plans. The continuity in top leadership and unmodified audit opinion provide further confidence in the company's governance and trajectory.
UGRO Capital Allots USD 20 Million Senior Secured Foreign Currency Bonds
UGRO Capital has successfully approved the allotment of USD 20 million in senior, secured, non-convertible foreign currency bonds through a private placement. The bonds carry a coupon rate of 300 basis points over Term SOFR and have a total tenure of 48 months. This fundraise, to be listed on the India International Exchange IFSC, demonstrates the company's ability to access international capital markets. The proceeds are expected to support the company's specialized lending operations in the SME sector.
Key Highlights
Issuance of 2,000 USD-denominated bonds with a face value of USD 10,000 each, totaling USD 20 million.
Coupon rate set at 300 basis points plus Term SOFR, with interest payable on a semi-annual basis.
Staggered redemption schedule: 25% at 36 months, 25% at 42 months, and 50% at 48 months maturity.
Secured by a first ranking exclusive charge over identified book debts with a minimum 110% security cover.
👀 What to Watch
Investors should monitor the company's ability to maintain its net interest margins (NIMs) as it utilizes these foreign currency funds for domestic lending. The successful international fundraise is a positive indicator of institutional confidence in UGRO's balance sheet.
UGRO Capital Allots NCDs Worth ₹181.10 Crore via Private Placement
UGRO Capital has approved the allotment of two series of Non-Convertible Debentures (NCDs) totaling ₹181.10 crores. Series I consists of ₹46.10 crores in subordinated unsecured debt with a high coupon rate of 13.25% and a 6-year tenure. Series II involves ₹135 crores in senior secured debt at a 9.50% interest rate with a shorter tenure of approximately 13 months. This capital infusion is intended to support the company's lending operations and growth in the MSME sector.
Key Highlights
Total fundraise of ₹181.10 crores through private placement of NCDs approved on March 27, 2026.
Series I: ₹46.10 crore subordinated unsecured NCDs at 13.25% p.a. with maturity in April 2032.
Series II: ₹135 crore senior secured NCDs at 9.50% p.a. with maturity in April 2027.
Series II debt is secured by a pledge of equity shares as per the Debenture Trust Deed.
Series I features a staggered redemption with 50% at 66 months and 50% at 72 months.
👀 What to Watch
Investors should view this as a positive sign of the company's ability to secure diverse funding; however, the 13.25% rate on subordinated debt indicates a high cost of long-term capital that needs to be offset by strong lending margins.
UGRO Capital to Raise Up to ₹205 Crore via Private Placement of NCDs
UGRO Capital's Investment and Borrowing Committee has approved the issuance of Non-Convertible Debentures (NCDs) totaling up to ₹205 crores. The fundraise is split into ₹155 crores of secured NCDs and ₹50 crores of unsecured subordinated NCDs. The secured portion carries a 9.50% monthly coupon with a short tenure of approximately 13 months, while the subordinated debt offers a 13.25% semi-annual coupon over 72 months. This capital infusion is aimed at strengthening the company's lending capacity and supporting its growth trajectory in the MSME sector.
Key Highlights
Total fundraise of up to ₹205 crores approved through two distinct NCD instruments.
₹155 crore secured NCDs feature a 9.50% monthly coupon and a tenure of ~13 months.
₹50 crore unsecured subordinated NCDs carry a higher coupon of 13.25% with a 6-year tenure.
Tentative allotment date for the securities is scheduled for March 27, 2026.
Secured NCDs are backed by a first-ranking pledge over equity shares and hypothecation of receivables.
👀 What to Watch
Investors should view this as a positive sign of liquidity and lender confidence, though the 13.25% cost on subordinated debt warrants monitoring of net interest margins. Watch for the company's upcoming quarterly results to see how effectively this capital is being deployed into AUM growth.
UGRO Capital Board to Meet on March 21 to Consider Fundraise via NCDs
UGRO Capital has scheduled a meeting of its Investment and Borrowing Committee for March 21, 2026, to discuss raising capital. The company intends to issue Non-Convertible Debentures (NCDs) through a private placement basis. This is a routine but essential activity for an NBFC to fuel its lending growth and manage liquidity. The specific quantum of the fundraise and the interest rates will be finalized during the upcoming committee meeting.
Key Highlights
Board meeting scheduled for March 21, 2026, to approve fund raising
Issuance of Non-Convertible Debentures (NCDs) via private placement
Compliance with SEBI LODR Regulations 29 (1) (d) and 50 (1) (d)
Funding intended to support the company's capital requirements for lending operations
👀 What to Watch
Investors should monitor the outcome of the March 21 meeting to understand the scale of the fundraise and the cost of debt, which will influence the company's net interest margins.
UGRO Capital Board to Meet on March 21 to Approve Fundraise via NCDs
UGRO Capital's Investment and Borrowing Committee is scheduled to meet on March 21, 2026, to discuss a potential fundraise. The company intends to issue Non-Convertible Debentures (NCDs) through a private placement basis. This is a standard procedure for NBFCs to secure capital for their credit disbursement activities. The specific financial details, such as the total amount to be raised and the coupon rate, will likely be disclosed following the committee's approval.
Key Highlights
Investment and Borrowing Committee meeting scheduled for March 21, 2026
Proposal to raise funds via Non-Convertible Debentures (NCDs)
Fundraising to be conducted through a private placement route
Move intended to strengthen the company's capital base for lending operations
👀 What to Watch
Investors should monitor the post-meeting announcement for the specific amount and coupon rate of the NCDs. This is a routine capital-raising exercise for an NBFC and does not immediately change the company's valuation.
UGRO Capital Allots Secured NCDs Worth ₹45 Crore at 9.50% Interest
UGRO Capital has approved the allotment of 45,000 secured, non-convertible debentures (NCDs) to raise ₹45 crore through a private placement. These instruments carry a coupon rate of 9.50% per annum, with interest payable on a monthly basis. The NCDs have a short-term tenure of 13 months, maturing on April 18, 2027. This capital raise will likely be utilized to support the company's ongoing lending operations and strengthen its liquidity position.
Key Highlights
Total issue size of ₹45 crore through the allotment of 45,000 NCDs at ₹10,000 face value each
Fixed coupon rate of 9.50% per annum with a monthly payment schedule
Short-term maturity period of 13 months from the date of allotment
Secured by a first-ranking exclusive pledge over equity shares as collateral
Default interest rate set at coupon rate plus 2.0% per annum for delays exceeding three months
👀 What to Watch
Investors should view this as a routine but positive liquidity-enhancing measure for the NBFC. Monitor the company's ability to maintain its margins against this 9.50% cost of debt.
UGRO Capital to Raise Over ₹530 Crores via NCDs and USD Denominated Bonds
UGRO Capital has approved the issuance of multiple debt instruments on a private placement basis to bolster its capital position. The fundraise includes domestic senior secured NCDs worth ₹300 crores and subordinated unsecured NCDs worth ₹65 crores with tenures up to 72 months. Additionally, the company is tapping international markets for USD 20 million (approx. ₹167 crores) through External Commercial Borrowings (ECBs). This diversified borrowing strategy aims to provide long-term liquidity and support the company's MSME lending growth.
Key Highlights
Approved issuance of senior secured NCDs totaling ₹300 crores with coupon rates between 9.50% and 9.75%.
Raising ₹65 crores through unsecured subordinated NCDs with a long-term maturity of 72 months.
Securing USD 20 million via foreign currency bonds at a floating rate of 6-month SOFR plus 300 bps.
Diverse debt maturity profile created with tenures ranging from 13 months to 6 years.
Security for NCDs includes a pledge of shares in Profectus Capital and 1.1x cover on identified book debts.
👀 What to Watch
Monitor the successful placement of these instruments as they provide the necessary leverage for AUM growth. Investors should track the impact of these borrowing costs on the company's overall Net Interest Margins (NIMs).
UGRO Capital Board to Meet on March 11 to Approve Fundraise via NCDs
UGRO Capital's Investment and Borrowing Committee is scheduled to meet on March 11, 2026, to consider a fundraise. The company plans to issue Non-Convertible Debentures (NCDs) or Bonds through a private placement. This capital infusion is intended to support the company's lending business and growth objectives. The specific amount and terms of the issuance will be determined during the upcoming committee meeting.
Key Highlights
Board committee meeting scheduled for March 11, 2026, to approve fundraise.
Issuance of Non-Convertible Debentures (NCDs) or Bonds proposed.
Fundraising to be conducted via private placement basis.
Compliance with SEBI LODR Regulations 29(1)(d) and 50(1)(d).
👀 What to Watch
Investors should monitor the announcement on March 11 for the specific fundraise amount and interest rates. A successful debt raise will provide the necessary liquidity to expand the company's MSME loan portfolio.
UGRO Capital Revises MyShubhLife Acquisition to INR 38.23 Cr All-Cash Deal
UGRO Capital has amended its agreement to acquire 100% of Datasigns Technologies (MyShubhLife), shifting from a mixed cash-and-stock deal to an all-cash transaction. The total consideration has been reduced to INR 38.23 crores from the previously announced INR 45 crores, effectively preventing equity dilution for existing shareholders. The MyShubhLife platform is already deeply integrated, having facilitated an AUM of approximately INR 1,720 crores as of December 31, 2025. This acquisition solidifies UGRO's embedded finance ecosystem and digital MSME lending capabilities.
Key Highlights
Acquisition price reduced by 15% from INR 45 crores to INR 38.23 crores
Payment structure changed to 100% cash in a single tranche to avoid equity dilution
Target platform MyShubhLife already manages an AUM of INR 1,720 crores for UGRO
Acquisition completes the transition of Datasigns Technologies into a wholly owned subsidiary
Strategic focus on embedded finance for MSME credit origination strengthened
👀 What to Watch
Investors should view this as a positive development as the company secured a lower purchase price and avoided dilution while acquiring a proven technology asset. Monitor the continued growth of the embedded finance AUM as a key performance indicator.
